Related Experiment Video
Updated: Sep 20, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Heparin as an inhibitor of L-arginyl-tRNA: protein arginyltransferase
Abstract:
Heparin, a naturally occurring mucopolysaccharide, was found to be a potent inhibitor of L-arginyl-tRNA:protein arginyltransferase [EC 2.3.2.8]. It was demonstrated that heparin was not an acceptor of arginine, but an inhibitor competing with arginyl-tRNA. The Ki value of heparin was 1.5 microM, while the Km value of arginyl-tRNA was 0.5 microM. The inhibition was specific for heparin among the mucopolysaccharides examined. The N-sulfate groups were indispensable for heparin to inhibit the arginyltransferase activity. Arginyltransferases from various origins were commonly inhibited by heparin. Polyamines such as spermine and spermidine were also found to inhibit the transferase activity, competing with arginyl-tRNA. An extremely high specific activity of 2.3 mumol/min/mg was achieved by the application of these inhibitors to the purification of the transferase by affinity chromatography.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Venous Thrombosis III: Interprofessional Care
Inhibitors of Viral Protein Synthesis

